See more : TimkenSteel Corporation (TMST) Income Statement Analysis – Financial Results
Complete financial analysis of LiveWire Ergogenics, Inc. (LVVV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LiveWire Ergogenics, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- InternetArray, Inc. (INAR) Income Statement Analysis – Financial Results
- Clariant Chemicals (India) Limited (CLNINDIA.NS) Income Statement Analysis – Financial Results
- Recharge Acquisition Corp. (RCHGW) Income Statement Analysis – Financial Results
- TG Venture Acquisition Corp. (TGVCU) Income Statement Analysis – Financial Results
- Accor SA (ACCYY) Income Statement Analysis – Financial Results
LiveWire Ergogenics, Inc. (LVVV)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://livewireergogenics.com
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics Inc. focuses on acquiring, managing, and licensing special purpose real estate properties to produce handcrafted and organically grown cannabis products for medical and recreational adult-use in California. The company is based in Anaheim, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.63M | 1.94M | 851.20K | 580.32K | 344.23K | 35.71K | 0.00 | 9.07K | 45.13K | 238.96K | 146.17K | 148.03K | 402.34K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 39.38K | 133.17K | 149.65K | 203.81K | 147.21K | 177.92K | 0.00 | 8.00K | 49.95K | 240.62K | 93.59K | 137.02K | 258.48K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.59M | 1.80M | 701.55K | 376.51K | 197.03K | -142.21K | 0.00 | 1.07K | -4.82K | -1.66K | 52.58K | 11.02K | 143.86K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 97.59% | 93.13% | 82.42% | 64.88% | 57.24% | -398.24% | 0.00% | 11.83% | -10.69% | -0.70% | 35.97% | 7.44% | 35.76% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 841.88K | 1.55M | 7.92M | 768.27K | 0.00 | 0.00 | 2.83M | 869.13K | 1.61M | 524.16K | 121.36K | 42.67K | 116.14K | 142.48K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 841.04K | 1.23M | 0.00 | 0.00 | 0.00 | 0.00 | 55.76K | 64.68K | 69.93K | 10.27K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 764.38K | 1.16M | 3.19M | 841.88K | 1.23M | 7.92M | 768.27K | 19.90K | 336.36K | 2.88M | 933.81K | 1.68M | 534.43K | 121.36K | 42.67K | 116.14K | 142.48K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 764.38K | 1.16M | 3.19M | 841.88K | 1.23M | 7.92M | 768.27K | 19.90K | 336.36K | 2.89M | 940.89K | 1.68M | 534.43K | 121.36K | 42.67K | 130.84K | 163.50K |
| Cost & Expenses | 803.76K | 1.29M | 3.34M | 1.05M | 1.38M | 8.10M | 768.27K | 27.90K | 386.32K | 3.13M | 1.03M | 1.82M | 792.90K | 121.36K | 42.67K | 130.84K | 163.50K |
| Interest Income | 346.91K | 288.64K | 178.32K | 33.17K | 0.00 | 747.81K | 474.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 245.32K | 249.24K | 605.21K | 666.38K | 1.05M | 0.00 | 0.00 | 59.46K | 153.32K | 653.92K | 59.20K | 21.02K | 2.38K | 10.94K | 0.00 | 11.00K | 0.00 |
| Depreciation & Amortization | 39.38K | 133.17K | 149.65K | 163.81K | 137.02K | 117.87K | 768.27K | 1.28K | 4.34K | 4.66K | 7.08K | 6.20K | 3.90K | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 1.22M | 1.07M | -2.68M | -301.56K | -515.48K | -10.73M | 41.80K | -17.55K | -332.69K | -3.30M | -881.23K | -1.67M | -386.66K | -121.36K | -32.67K | -130.84K | -163.50K |
| EBITDA Ratio | 74.45% | 40.14% | -275.00% | -51.96% | -260.77% | -22,255.68% | 0.00% | -193.47% | -746.40% | -1,207.30% | -602.89% | -1,124.52% | -96.10% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 829.99K | 644.73K | -2.49M | -465.37K | -1.03M | -8.07M | -768.27K | -18.83K | -341.19K | -2.89M | -888.31K | -1.67M | -390.56K | -121.36K | -52.67K | -130.84K | -163.50K |
| Operating Income Ratio | 50.80% | 33.27% | -292.58% | -80.19% | -300.57% | -22,585.76% | 0.00% | -207.58% | -756.02% | -1,209.25% | -607.73% | -1,128.71% | -97.07% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 91.59K | 39.39K | -941.99K | -1.16M | -672.00K | -3.53M | -432.65K | -59.45K | -149.16K | -1.29M | -377.63K | -31.92K | -2.38K | 0.00 | 10.00K | 0.00 | 0.00 |
| Income Before Tax | 921.58K | 684.12K | -3.43M | -1.62M | -1.71M | -11.59M | -1.20M | -78.28K | -490.34K | -4.18M | -1.27M | -1.70M | 0.00 | 0.00 | -42.67K | 0.00 | 0.00 |
| Income Before Tax Ratio | 56.41% | 35.30% | -403.25% | -279.33% | -495.79% | -32,464.82% | 0.00% | -863.01% | -1,086.51% | -1,750.74% | -866.08% | -1,150.28% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -5.00 | 4.00 | 4.00 | -20.11K | 68.97K | -4.00 | -769.81K | -1.00 | 0.00 | 653.92K | 59.20K | 21.02K | 2.38K | 121.36K | -10.00K | 156.84K | 152.62K |
| Net Income | 921.58K | 684.12K | -3.43M | -1.60M | -1.78M | -11.59M | -1.20M | -78.28K | -490.34K | -4.18M | -1.27M | -1.70M | -392.95K | -121.36K | -32.67K | -156.84K | -152.62K |
| Net Income Ratio | 56.41% | 35.30% | -403.25% | -275.87% | -515.83% | -32,464.82% | 0.00% | -863.01% | -1,086.51% | -1,750.74% | -866.08% | -1,150.28% | -97.66% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | -0.03 | -0.02 | -0.03 | -0.01 | 0.00 | -0.01 | -0.03 | -0.03 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | -0.03 | -0.02 | -0.03 | -0.01 | 0.00 | -0.01 | -0.03 | -0.03 |
| Weighted Avg Shares Out | 1.85B | 1.79B | 1.58B | 1.20B | 1.11B | 952.71M | 682.73M | 527.12M | 284.80M | 133.04M | 75.07M | 65.12M | 57.73M | 36.00M | 5.92M | 5.92M | 5.92M |
| Weighted Avg Shares Out (Dil) | 1.94B | 1.88B | 1.58B | 1.20B | 1.11B | 952.71M | 682.73M | 527.12M | 284.80M | 133.04M | 75.07M | 65.12M | 57.73M | 36.00M | 5.92M | 5.92M | 5.92M |
UPDATE - LiveWire Ergogenics Reports 2020 Financial Performance
Anaheim, CA, March 30, 2021 (GLOBE NEWSWIRE) -- LiveWire Ergogenics Inc. (OTC: LVVV), a company focused on acquiring and managing special purpose real estate properties and the associated operation permits conducive to the production of high-quality, handcrafted and organically grown...
LiveWire Ergogenics Reports 2020 Financial Performance
Anaheim, CA, March 30, 2021 (GLOBE NEWSWIRE) -- March 30, 2021 - LiveWire Ergogenics Inc. (OTC: LVVV), a company focused on acquiring and managing special purpose real estate properties and the associated operation permits conducive to the production of high-quality,...
LiveWire Ergogenics Issues Shareholder Letter and Provides Corporate Update for 2021
Anaheim, CA, Jan. 15, 2021 (GLOBE NEWSWIRE) -- LiveWire Ergogenics Inc. (OTC: LVVV), a company focused on acquiring, managing, and licensing special purpose real estate properties conducive to produce high-quality, handcrafted and organically grown cannabis products for medical and recreational adult-use...
Source: https://incomestatements.info
Category: Stock Reports